Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. EFFECT Other Notice of Effectiveness
  4. 424B3 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. S-3 Offering Registration Statement
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. D Other Notice of Sales of Unregistered Securities
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  19. 8-K Event Executive or director change
  20. EFFECT Other Notice of Effectiveness

Page 4 of 18 · 348 filings